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A pathogen’s ability to engage host receptors is a
critical determinant of its host range and interspe-
cies transmissibility, key issues for understanding
emerging diseases. However, the identification of
host receptors, which are also attractive drug tar-
gets, remains amajor challenge. Our structural bioin-
formatics studies reveal that both bacterial and viral
pathogens have evolved to structurally mimic native
host ligands (ligand mimicry), thus enabling engage-
ment of their cognate host receptors. In contrast
to the structural homology, amino acid sequence
similarity between pathogen molecules and the
mimicked host ligands was low.We illustrate the util-
ity of this concept to identify pathogen receptors by
delineating receptor tyrosine kinase Axl as a candi-
date receptor for the polyomavirus SV40. The SV40-
Axl interaction was validated, and its participation
in the infection process was verified. Our results
suggest that ligand mimicry is widespread, and we
present a quick tool to screen for pathogen-host
receptor interactions.
INTRODUCTION
Mimicry is a widespread phenomenon by which an organism,
cell, or protein impersonates another to compete for similar
resources or gain other advantages. One form of mimicry
commonly employed by pathogens is molecular mimicry,
defined as ‘‘pathogen-encoded factors that resemble host fac-
tors in order to co-opt or disrupt host functions to the pathogen’s
advantage,’’ (Elde and Malik, 2009). For example, herpes and
pox viruses encode for homologs of soluble host immune mod-
ulators, such as chemokines and cytokines, to achieve immune
evasion (Alcami, 2003; Benedict, 2003; Bernet et al., 2003).
Another example is bacterial virulence factors that interfereCwith normal host processes bymimicking essential host proteins
(Gala´n, 2009; Izard et al., 2006; Stebbins and Gala´n, 2001).
Molecular mimicry has been suggested as an explanation for
the correlation between some autoimmune syndromes and spe-
cific infections, such as the increased risk for developingmultiple
sclerosis after Epstein-Barr virus (EBV) infection (Lucas et al.,
2011). These autoimmune syndromes are thought to result
from cross-reaction of the antibodies generated to neutralize
the infecting agent with host proteins (Delogu et al., 2011), sug-
gesting structural similarities between some proteins of patho-
gens and their hosts.
Molecular mimicry may arise via divergent or convergent evo-
lution. Divergent evolution starts with the acquisition of a host
genomic segment via horizontal gene transfer, followed by
selection to increase the pathogen’s fitness. This often results
in significant sequence similarity between the pathogen protein
and the host protein beingmimicked. On the other hand, mimicry
may evolve through convergent evolution, whereby a pathogen-
encoded protein acquires structural features of a host protein,
presumably via random mutations and natural selection. Such
mimicry events are likely to lead to structural similarity with min-
imal sequence homology.
The identification of host receptors used by microbial life
forms, both bacteria and viruses, to enter and infect host cells
remains a major problem in the field of microbiology today. We
have speculated that viruses and bacteria may use molecular
mimicry for host recognition in order to attach to host receptors.
According to our hypothesis, mimicry of native cellular ligands
would facilitate direct interaction between the pathogen mimic
and the respective host receptor. Indeed, as described below,
our in silico studies provide support for the concept of ligand
mimicry among bacteria as well as viruses.
A practical prediction was that such molecular mimicry, which
we termed ligand mimicry, would provide a simple method to
identify host receptors used by pathogens. Based on the known
structure of the simian virus 40 (SV40) major capsid protein and
the ligandmimicry hypothesis, we were able to identify, among a
number of additional putative receptors, the receptor tyrosine
kinase Axl as a cellular receptor for SV40. In vitro and cell culture
experiments validated this prediction, attesting to the feasibilityell Host & Microbe 14, 63–73, July 17, 2013 ª2013 Elsevier Inc. 63
Table 1. Microbial Surface Proteins Are Structurally Similar to Host Ligands of Their Respective Receptors
Microbe Family
Microbe Surface
Protein
Eukaryotic Ligand
Homologa Z score
Sequence
identity (%) Known Receptor(s)
Yersinia
pseudotuberculosis
Enterobacteriaceae
(Gram-negative)
invasin integrin av (5) 8 7 integrin b1
transglutaminase (4) 8.2 9
Herpes simplex virus 1 Herpesviridae (dsDNA,
enveloped)
glycoprotein D nectin-1 (3) 8.4 11 nectin-1 and nectin-2
nectin-2 (3) 7.4 11
TIGIT (1) 7.9 14
BTLA (1) 5.7 10 HVEM
West Nile virus Flaviviridae (ssRNA,
enveloped)
glycoprotein E fibronectin (30) 6.2 10 integrin aVb3
Escherichia coli Enterobacteriaceae
(Gram-negative)
DraE complement C3b (5) 2.9 6 DAF
Echovirus 7 Picornaviridae (ssRNA,
nonenveloped)
VP2 complement C3b (5) 2.8 6 DAF
Adenovirus 21 Adenoviridae (dsDNA,
nonenveloped)
fiber knob complement C3b (5) 3.2 9 CD46
Average 6 9.4
For each microbial surface protein, structurally homologous ligands are listed. Homologous structures were detected using DALI (see Supplemental
Experimental Procedures). The corresponding statistical significance (Z score) and the percentage of sequence identity between the proteins is
indicated.
aThe number in brackets indicates the number of distinct domains in the mimicked ligand, based on annotations from the Pfam database. In all cases,
the domain in the ligand that interacts with the receptor is the domain identified by our screen to be mimicked by the MSP. See also Figure S1 and
Table S1.
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receptor interactions.
RESULTS
Ligand Mimicry Is Widespread among Bacteria
and Viruses
To test our hypothesis that structural mimicry plays a role in
receptor recognition, we constructed a data set of known
microbe-receptor interactions fromavailable literature. A prereq-
uisite was that the microbe surface protein (MSP) involved in the
interaction had been identified and its structure solved. We thus
ended up with a set of 24 interactions, including 17 virus-recep-
tor and 7 bacterium-receptor interactions. We then set out to
investigate if we could identify structural similarities between
MSPs and known host ligands of their respective receptors.
Themethodology is described in the Supplemental Experimental
Procedures and Figure S1 (available online). In short, we used
the DALI algorithm (Holm and Rosenstro¨m, 2010; Holm and
Sander, 1995) to search the Protein Data Bank (PDB) for struc-
tural homologs of the MSPs (Figures S1A and S1B). A structural
homolog was defined as a protein in the PDB that was structur-
ally similar to the MSP with a Z scoreR 2. Z score is a statistical
measurement of the likelihood of structural similarity between
two proteins. A Z score of 2 corresponds to a p value of 0.05.
In the PDB, the screen typically identified hundreds of homologs
for each MSP. Since we focus here on the initial step of cell
recognition, we confined the search to proteins annotated by
UniProt (www.uniprot.org/) to be native ligands of host receptors
known to interact with the specific MSP (Figure S1C).
For 6 of the 24 MSPs screened, DALI has identified a small
number of host proteins that are ligands of receptors known to64 Cell Host & Microbe 14, 63–73, July 17, 2013 ª2013 Elsevier Inc.be engaged by the respective microbe. Notably, these six
MSPs were from evolutionarily unrelated organisms, including
Gram-negative pathogenic bacteria, as well as DNA and RNA vi-
ruses from different families, both enveloped and nonenveloped
(Herpesviridae, Flaviviridae, Picornaviridae, and Adenoviridae)
(Table 1). These ligands range from 3 to 25 for the various
MSPs and thus represent only2% of the total number of signif-
icant homology hits. Table S1 presents the ligands identified by
DALI, with their PDB accession numbers. We considered these
ligands as candidates of mimicry by the MSPs. We note that
some of the mimicked proteins are genuine host ligands,
whereas others are dimerization partners of the host receptor
(see Figure 1A). For simplicity, we refer to these mimicry candi-
dates collectively as ligands.
From the list of mimicry-candidate ligands, we further selected
ligands that interact with receptors known to be used by the
respective microbe. These are highlighted in yellow in Table S1.
If the ligand mimicry hypothesis is correct, we expect that the
structural similarity between a mimicked ligand and its MSP
would encompass the receptor-binding domain of the ligand.
To test this prediction, we superimposed the MSP structure
onto the ligand-receptor complex structure (Figure S1D) using
pairwise structural comparison with the DaliLite web server,
version 3.1 (Hasegawa and Holm, 2009), which indicated the
relative orientation of the MSP and the host ligand. Encourag-
ingly, we found that the ligand domains mimicked by MSPs are
indeed those that interact with the receptors, providing initial
support for the ligand mimicry concept. When available, we
used the solved ligand-receptor complex structure (see Table
S1 for PDB IDs). When not available, we applied the PatchDock
docking protocol (Schneidman-Duhovny et al., 2005) to model
the host ligand-receptor complex from the structures of the
Figure 1. Testing the Ligand Mimicry
Hypothesis through Known Microbe-Host
Interactions
(A–G) Throughout the figure, MSPs are shown in
red, the mimicked ligands in green, and the
respective human receptors in blue. PDB IDs of
the MSPs, their ligands, and available ligand
receptor complexes are presented in Table S1. 3D
structures of the complexes are in Figure S2.
(A) Schematic representation of the two forms of
ligand mimicry. Left panel: an MSP that mimics a
soluble host ligand; right panel: an MSP that
mimics a receptor dimerization partner.
(B) YersiniaMSP invasin (red) superimposed on its
mimicked ligand integrin aV, bound to its receptor
integrin b1.
(C) HSV-1 MSP gD superimposed on one mono-
mer of the nectin-1 receptor, which is bound to the
other monomer. Interestingly, this orientation
causes a clash between gD and nectin-1, involving
mainly residues 37–56 and 198–219 in gD. This
predicts conformational rearrangement of gD and/
or nectin-1 upon their interaction.
(D) WNV MSP gE superimposed on the FN7–FN10
domains of human fibronectin. Integrin aVb3 is not
shown, as structure of its complex with fibronectin
is not known.
(E–G) Since the structure of the complexes
between C3b and its receptors DAF and CD46
have not been solved, we modeled these
interactions by docking the structure of C3b
(green, E–G) to the structures of DAF (blue, E and F)
or CD46 (blue, G) using the PatchDock web server
(Schneidman-Duhovny et al., 2005). We then
superimposed the structures of the MSPs (red)
DraE (E), VP2 (F), and fiber knob (G), based on the
DALI search results. PatchDock predicts that DAF
interacts with C3b at two domains: in the middle of
the C3b molecule and at its lower domain. The
middle C3b domain is the one mimicked by both
E. coliDraE (E) and echovirus 7 VP2 (F). In contrast,
adenovirus 21 fiber knob mimics a different C3b
domain, predicted by PatchDock to interact with
CD46 (G).
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MSPs onto the ligand-receptor complexes along with the Z
score and rmsd (the root-mean-square deviation, which is a
measure of the average distance between the backbone atoms
of the superimposed proteins). Full three dimensional (3D) views
of the superimpositions are available in Figure S2. The findings
obtained by these superimpositions are described below.
Yersinia pseudotuberculosis is a foodborne pathogen, causing
fever and abdominal pain in infected humans (Nuorti et al., 2004).
Y. pseudotuberculosis attaches to host cells via its MSP invasin.
Invasin was shown to bind to several b1-type integrin host
receptors (Isberg and Leong, 1990). We identified 13 distinct
host ligand homologs of invasin in the PDB (Table S1). Two
of these, transglutaminase and integrin aV, are known to bindCell Host & Microbe 14, 6to the b1-integrin receptor (Tables 1
and S1). To model how the MSP might
interact with this receptor, we superim-
posed invasin onto the integrin aV-integ-rin b1 heterodimer complex structure (Xiong et al., 2002) based
on theDALI output. In agreement with the ligandmimicry hypoth-
esis, invasin mimics a domain of integrin aV that directly partic-
ipates in receptor binding (Figure 1B). In addition to mimicking
ligands of its known receptor, integrin b1, we found that inva-
sin also mimics several other host ligands, suggesting that
Y. pseudotuberculosis may bind to additional host receptors
(Table S1).
Herpes simplex virus 1 (HSV-1) is a prevalent human path-
ogen. An MSP of HSV-1, envelope glycoprotein D (gD), is known
to bind to three host receptors: nectin-1, nectin-2, and herpes
virus entry mediator (HVEM) (reviewed in Spear, 2004). B and
T lymphocyte attenuator (BTLA), a known ligand of the HVEM
receptor (Sedy et al., 2005), was among the 25 ligands identified3–73, July 17, 2013 ª2013 Elsevier Inc. 65
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directly compete with BTLA for binding to HVEM (Stiles et al.,
2010), a compelling demonstration of the ligand mimicry
hypothesis.
In addition, gD was also found to mimic TIGIT (T cell immunor-
eceptor with immunoglobulin and ITIM domains) (Tables 1
and S1), a ligand of the other receptors used by HSV-1, nectin-1,
and nectin-2 (Stanietsky et al., 2009). Furthermore, gDwas found
to be a structural homolog of the very receptors it engages: nec-
tin-1 and nectin-2. Superimposition of gD on the nectin-1 homo-
dimer shows that gD mimics the nectin-1 homodimerization
domain (Figure 1C). Thus, in this case, the MSP interacts
with the receptor by targeting the dimerization interface. Our
results are in agreement with a recent publication that demon-
strated that gD binding to nectin-1 is similar to the mode of
nectin-1 homodimer formation (Zhang et al., 2011). Interestingly,
positioning gD in this orientation leads to a considerable
clash at the interface between gD and the bound nectin-1,
suggesting that binding induces a significant conformational
change in gD (and nectin) (Figure 1C). Thus, strikingly, through
a search for gD structural homologs, we were able to identify
all three known HSV-1 receptors. In addition to these, our screen
also predicts additional potential host receptors for HSV-1
(Table S1).
West Nile virus (WNV) is another neurotropic virus that infects
humans via a mosquito vector. To initiate cell entry, the WNV
MSP, envelope glycoprotein E (gE), binds the host receptor
integrin aVb3 (Chu and Ng, 2004). The integrin aVb3 ligand fibro-
nectin was among the identified 23 ligands homologous of gE
(Table S1). The structural homology between gE and fibronectin
is restricted to the FN10 domain of fibronectin (Figure 1D), sug-
gesting that this very domain is involved in the native fibronectin-
integrin complex formation. Fibronectin binding to integrin aVb3
was indeed previously shown to be mediated by the fibronectin
domains FN9–FN10 (Adair et al., 2005). Thus, our results suggest
that WNV too achieves receptor recognition via ligand mimicry.
As in the other examples described above, we found additional
host ligands that might be mimicked by gE (Table S1).
Ligand Mimicry of C3b
Intriguingly, three of the screened MSPs, E. coli DraE, echovirus
7 (EV7) VP2, and adenovirus 21 (Ad21) fiber knob protein, were
found to mimic the same human ligand, complement protein
C3b (Table S1). C3b is a known ligand of DAF (decay accelera-
tion factor), a receptor used by both E.coli DraE (Korotkova
et al., 2008) and EV7 VP2 (Clarkson et al., 1995). C3b is also a
ligand of CD46, the receptor used by Ad21 fiber knob (Cupelli
et al., 2010).
Superimposition of the E. coli DraE (red) and C3b (green)
shows that, as in the previous examples, the homology is limited
to a single domain of the mimicked ligand (Figure 1E). Since the
structure of the C3b-DAF native interaction has not yet been
solved, we have used PatchDock to create a model structure
of the complex based on the structures of free C3b and DAF.
Consistent with the mimicry hypothesis, we indeed see that
the superimposition of E. coli DraE onto the modeled C3b-DAF
complex positions the MSP at the very C3b-DAF interface (Fig-
ure 1E). Furthermore, superimposition of the echovirus 7 VP2
on the C3b-DAF complex suggests that VP2 mimics the same66 Cell Host & Microbe 14, 63–73, July 17, 2013 ª2013 Elsevier Inc.domain of C3b that is mimicked by E. coli DraE (Figure 1F). On
the other hand, structural prediction (by PatchDock) of the
C3b-CD46 complex and superimposition with the Ad21 fiber
knob suggests that the latter interacts with its receptor by
mimicking a different domain of C3b. Thus, two distinct domains
of a single ligand, which are used for attachment to two different
human receptors, are mimicked by different microbes in accor-
dance with their respective targets, attesting to the power of
ligand mimicry.
Ligand Mimicry Predicts that SV40 Interacts with
Several Host Receptor Families
Since knowledge of pathogen receptors, which are attractive
targets for drug design, is rather limited, we next explored
whether ligand mimicry may be used to reveal virus-receptor
interactions. We chose to focus on SV40, a small, nonenveloped
DNA virus whose only well-established cellular receptor until
recently was the ganglioside GM1 (Neu et al., 2008). Since
SV40 infection leads to initiation of a complex signaling network
(Butin-Israeli et al., 2010; Pelkmans et al., 2005) that cannot be
explained merely by its binding to GM1, we hypothesized that
additional protein receptors participate in the infection.
The SV40 major capsid protein, VP1, is the only viral protein
exposed to the cell surface, making it an ideal candidate to
test our hypothesis. We identified >500 proteins as structural
homologs of the SV40 VP1, the majority of which belong to the
viral coat protein superfamily. Nevertheless, our search also
revealed 17 ligands of a number of host receptors (Figure 2A).
The average sequence identity of these proteins to VP1 is low
(7.2%), making them undetectable by sequence homology ap-
proaches. The predicted receptors included three receptor fam-
ilies (TAM receptors, tumor necrosis factor [TNF]-like receptors,
and integrins) and seven additional receptors (neuropilin-1, CR1,
CD93, DAF, CD46, ephrin-B2, and CD36).
To test the validity of the structural screen, we examined
whether SV40 binds to the predicted receptors in vitro. We
used a high-throughput microfluidic platform that measures
affinities of binding by mechanical trapping of molecular interac-
tions. The system facilitates concomitant testing of SV40 binding
to most of the predicted receptors (for details see Supplemental
Experimental Procedures). We used Cy5-labeled SV40 and
measured its binding to members of the 3 receptor families
(TAM, TNF receptors, and integrins) and 2 of the 7 additional
receptors (a total of 26 predicted human receptors). As negative
controls, we used a set of 17 receptors that were not predicted
by the bioinformatics study to interact with the virus. The results
are summarized in Figure 2B. The y axis depicts the statistical
significance for the interaction between the receptor and SV40,
presented as p value. The horizontal red line designates the
threshold of significant interactions (p value of 0.05). SV40 has
been found to bind to 73% of the predicted receptors, while no
binding was observed to the negative controls (pooled together
and presented as a black column). The data suggest that the
virus may use a wide spectrum of receptors in addition to
GM1, accounting for its broad cellular tropism. Note that SV40
bound to most, but not all, members of receptor families identi-
fied by the structural screen to bind the virus. Thus, information
obtained by this high-throughput method is useful for focusing
validation experiments on those receptors that bind SV40.
Figure 2. Potential SV40 Receptors Predicted by the Ligand Mimicry Hypothesis
(A) Screening by DALI for ligands that are potentially mimicked by SV40. The table lists eukaryotic ligands with significant structural similarity to SV40 VP1
(Z scoreR 2) and their respective receptors.
(B) Binding of SV40 to 26 of the receptors identified by the DALI screen. Binding was measured using the microfluidic platform described in the text and in
Experimental Procedures. The experiment was performed in quadruplicates. The columns present the probability of SV40 binding to the receptors. The horizontal
red line marks the threshold of significant interactions (p value of 0.05). All bars that pass the value represent significant p values (the y axis is in inverted log scale,
thus depicting logarithmic increase in significance). These results show that SV40 binds tomembers of each of the predicted families of receptors identified by the
ligand mimicry hypothesis. NC is a group of negative controls pooled together.
(C) SV40 binds more strongly to the receptors predicted by the DALI search than to a random set of receptors. SV40 binding to the random set is not significantly
different than its binding to the negative controls (p value = 0.3). The results aremean ± SE of the fluorescent intensity of the receptors bound toCy5-labeled SV40.
*p value = 0.0002.
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binding to the predicted receptors with its binding to a random
set of membrane proteins, measured in parallel in the same
experiment. As seen in Figure 2C, SV40 binding to the random
set of receptors was not significantly different from its binding
to the negative controls (24 ± 6 arbitrary units [AU] compared
to 29 ± 10, respectively; p value = 0.3). On the other hand,
SV40 binding to the predicted receptors was significantly stron-
ger than its binding to the random set (86 ± 14 AU, p value =
0.0002).
SV40 binding to integrins and their function in virus entry was
recently validated in a collaborative study between L. Pelkmans’
group and ours (Stergiou et al., 2013). Notably, in that study,
knockdown of b1 integrin had a strong effect in inhibiting SV40
infection. These findings are consistent with our present result,
which shows that SV40 binds to b1 integrin, but not to b2 or b5
(Figure 2B).
Taken together, these data show that unknown binding part-
ners of a virus (SV40 in this case) can be successfully identified
using the ligand mimicry concept.
SV40 VP1 Mimics Gas6, a Ligand of TAM Receptors
In the present study, we focused further on the predicted
interaction between SV40 and the small family of TAM (Tyro3,
Axl and Mer) tyrosine kinase receptors (Figure 3A). We modeledCthe VP1-TAM receptor interaction on the basis of the homology
between VP1 (red) and the ligand Gas6 (teal) and the available
structure of the Gas6-Axl complex (Sasaki et al., 2006) (Fig-
ure 3B, Axl is in blue). Superimposition of this complex onto
the complete viral capsid structure (which consists of 360 VP1
monomers arranged in 72 pentamers) demonstrates that the
Axl extracellular domain fits nicely into an accessible groove
formed between adjacent pentamers, as seen in the cluster of
7 pentamers that represent the entire capsid structure (Figure 3E
and Movie S1). Furthermore, this binding configuration is pre-
dicted to leave the binding site of SV40 to GM1 open (Figure 3E),
suggesting that SV40 might interact with both GM1 and TAM
receptors simultaneously.
In another approach, we modeled the VP1 pentamer-Axl
interaction using PatchDock (Figure S3). Note that this approach
is completely independent of the ligand mimicry concept and
relies merely on the known structures of VP1 and Axl. Among
the top ten results, six predictions were excluded because of
incompatibility with receptor binding, since they placed Axl at
the internal surface of the capsid. Of the remaining four, three
were very similar to the model obtained through the structural
homology study presented above. Thus, two unrelated bioinfor-
matics approaches predicted that TAM receptors could poten-
tially bind VP1 pentamers at similar positions of the capsid
surface.ell Host & Microbe 14, 63–73, July 17, 2013 ª2013 Elsevier Inc. 67
Figure 3. SV40 VP1 Mimicry of Gas6
(A) Superimposition of a VP1 monomer (red) with Gas6 (teal).
(B) Interaction of Gas6 (teal) with Axl (blue) as previously solved (Sasaki et al.,
2006).
(C) The structure from (A) superimposed on (B), showing a prediction of
the binding site of a VP1 monomer to Axl.
(D) Superimposition of a complete VP1 pentamer on the VP1 monomer-Axl
interaction shown in (C).
(E) The interaction of Axl with a seven-pentamer cluster of VP1, which repre-
sents the entire capsid structure. The central pentamer (red) is surrounded
by six gray pentamers, viewed from the top (left) and the side (right). This
extension of the model predicts that TAM receptors dock in the groove formed
betweenadjacentVP1pentamers. This configurationdoesnot interferewith the
binding of GM1 (green, shown in space fill). See also Figure S3 and Movie S1.
Table 2. Biacore Measurements of SV40 Interaction with Axl and
Tyro3
VLPs VP1 Pentamers
Axl KD (nM) 4.3 ± 1.9 940 ± 525
KA (1/M 3 s) 1.2 ± 0.6 3 10
6 2.5 ± 1.3 3 104
KD (1/s) 1.9 ± 0.2 3 10
3 1.5 ± 1.1 3 102
Tyro3 KD (nM) 2.5 ± 0.9 833 ± 48
KA (1/M 3 s) 7.9 ± 5 3 10
5 1.6 ± 1.3 3 104
KD (1/s) 1.2 ± 0.7 3 10
3 1.4 ± 1.2 3 102
Summary of binding measurements of SV40 VLPs and VP1 pentamers to
immobilized Axl and Tyro3. Results are mean ± SE from at least three
independent experiments. KD, binding affinity; KA, association constant;
KD, dissociation constant. See also Figure S4.
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To further validate the prediction of this structural study and
characterize the biophysical properties of the SV40-TAM recep-
tors interaction, we performed in vitro binding studies of SV40 to
TAM receptors using surface plasmon resonance. This method
allows determination of both the kinetics and affinities of the
studied interactions. Recombinant Axl and Tyro3 were immobi-
lized onto different flow cells of a CM5 Biacore chip, leaving
one flow cell (Fc1) as a control for nonspecific binding (Fc1
was activated and blocked immediately afterward with no
protein binding). For SV40 capsids, we have used recombinant
virus-like particles (VLPs; Sandalon and Oppenheim, 1997)
composed of the SV40 major capsid protein VP1 and which
are readily produced at the high concentration of capsids
required for this experiment. VLPs were flowed over the immobi-
lized receptors at a high ionic strength buffer, to eliminate
nonspecific binding of VLPs to the chip surface. Both Axl and
Tyro3 bound SV40 capsids at an affinity of 2–4 nM, substantiat-
ing the predicted interaction (Table 2). These experiments were
repeated four times using different preparations of VLPs. At least
four different data points (representing different VLP concentra-
tions) from each experiment were used to fit the data to a binding68 Cell Host & Microbe 14, 63–73, July 17, 2013 ª2013 Elsevier Inc.curve and extract the binding affinity and kinetic parameters
(Table 2).
The model presented in Figure 3E suggests that VP1 pentam-
ers cooperate in binding to TAM receptors, predicting that free
VP1 pentamers would bind the receptors at a lower affinity
than complete VLPs. We tested the prediction by comparing
binding of VLPs with that of free VP1 pentamers. Indeed the
affinity for VLPs (2–4 nM) was 3 orders of magnitude higher
than for free VP1 pentamers (1 mM). The rate of association
(KA) was 503 higher for VLPs compared to free pentamers,
and the dissociation rate (KD) was 103 lower (Table 2), suggest-
ing that the specific arrangement of VP1 pentamers in the SV40
capsid contribute to enhanced binding of TAM receptors and
supporting the structural model presented in Figure 3E. Notably,
binding affinity of free pentamers, albeit lower than that of VLPs,
was nevertheless three orders of magnitude higher than previ-
ously reported for the pentamer-GM1 interaction (1 mM; Neu
et al., 2008), which was demonstrated by a number of experi-
mental studies (Campanero-Rhodes et al., 2007; Ewers et al.,
2010; Neu et al., 2008; Tsai et al., 2003).
To estimate the stoichiometry of the SV40-TAM receptors
interactions, we conducted cosedimentation experiments. Con-
stant concentrations of recombinant Axl or Tyro3 (50 nM) were
incubated for 1 hr at room temperature with varying amounts
of VLPs and subsequently ultracentrifuged at 100,000 3 g for
30 min. Control experiments (not shown) demonstrated that at
this concentration, when the receptors were sedimented alone,
they remained in the supernatant. On the other hand, VLPs
sedimented to the bottom of the tube regardless of their concen-
tration (at least within the range studied here). Following cocen-
trifugation, supernatant samples were analyzed for the presence
of Axl or Tyro3 by SDS-PAGE and silver staining, and the amount
of receptor was quantified by densitometry. The results
(Figure S4) show that binding of VLPs to the receptors can be
detected at a VLP:receptor molar ratio of 14:1,000 (or 1:72).
At this ratio, 32% ± 5% of the input receptor cosedimented
with VLPs, corresponding to 20 receptor molecules (72 3
0.32 = 23) per 1 SV40 capsid.
SV40 Colocalizes with Axl Immediately after Adsorption
to the Plasma Membrane
Next, we asked whether SV40 binds to Axl at the cell mem-
brane. To answer this question, we allowed fluorescein
Figure 4. SV40 Colocalizes with Axl
Immediately after Adsorption
(A) Representative micrographs of colocalization
analysis of FITC-labeled VLPs with Axl and GM1
2 min after adsorption. Arrows indicate where
FITC-VLPs colocalize with both Axl and GM1. The
arrows point to VLP spots, hardly seen at the lower
magnification. The inserts showmagnification of a
region surrounding a VLP (circled in the FITC-VLP
field).
(B) Quantification of colocalization of FITC-labeled
VLPs with GM1, Axl, and transferrin receptor
(TfnR) 0–60 min following adsorption to CV1
cells. Mean ± SE are from three independent
experiments.
(C) Representative images of the PLA experi-
ments. The upper panels show the PLA spots
(yellow) and nuclei, counterstained with DAPI
(blue). The lower panels show the same micro-
graphs overlaid with their phase contrast channel.
The PLA channel was pseudocolored in yellow for
better visualization.
(D) Quantification of PLA spots. PLA spots were
scored in R20 fields of each experiment. The
results are presented as mean ± SE spots/field.
SV40 interaction with GM1 yielded more PLA
spots/field than its interaction with Axl, and both
were significantly higher than the negative control
(transferrin receptor). *p = 7 3 108, **p = 4 3
1010 (one-tailed t test). The p value obtained for
Axl is lower than that of GM1 due to the lower SD
between the Axl fields compared to the GM1
fields.
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cells derived from the kidney of an African green monkey, a
natural host of SV40. Examination by confocal microscopy
indicated transient colocalization of VLPs with Axl (Figures 4A
and 4B). About 40% of the VLPs were colocalized with Axl at
the end of the adsorption period (30 min at 4C), increasing
rapidly to 55% at 2 min following the shift to 37C, followed
by steady decline and reaching background level (estimated
by colocalization with transferrin receptor as a negative control)
about 1 hr after adsorption. Similar results were obtained
with nonlabeled, wild-type SV40 using immunostaining for
VP1 (not shown). In contrast, association of VLPs with GM1
remained high (70%) during the first hour after adsorption,
consistent with a previous report (Qian et al., 2009). The
transient nature of the SV40-Axl interaction suggests that the
function of Axl in SV40 infection is different from that of GM1,
which has been shown to participate in SV40 cell entry andCell Host & Microbe 14, 6trafficking to the endoplasmic reticulum
(ER) (Campanero-Rhodes et al., 2007;
Ewers et al., 2010; Neu et al., 2008;
Tsai et al., 2003).
As the resolution of confocal micro-
scopy is limited to 200–400 nm, we
next testedwhether SV40 comes in direct
contact with Axl. The proximity ligation
assay (PLA) identifies interactions over
distances below 30 nm (So¨derberg
et al., 2006). The assay relies on secondary antibodies with
linked DNA oligonucleotides. When these PLA probes are suffi-
ciently close, the DNA strands can interact through a subsequent
addition of two other circle-forming DNA oligonucleotides,
enabling ligation of the PLA probes. They are amplified via a roll-
ing circle polymerization using fluorescently labeled nucleotides,
creating PLA spots that are visible by fluorescent microscopy.
We performed PLA 2 min after SV40 adsorption, the time at
which colocalization peaked (Figure 4B). As seen in Figures 4C
and 4D, almost no signal was observed for the negative control
(transferrin receptor, average of 9 ± 1 PLA spots/field with
n = 22 fields counted), while abundant signals were observed
for both the VP1-Axl interaction (26 ± 2 spots/field; p value =
4 3 1010; n = 25 fields) and VP1-GM1 (43 ± 5 spots/field; p
value = 7 3 108; n = 20 fields). These data indicate that SV40
binds to Axl immediately after adsorption. Notably, the SV40-
GM1 interaction produced 60% more PLA signals compared3–73, July 17, 2013 ª2013 Elsevier Inc. 69
Figure 5. Role of Axl during SV40 Infection
(A) CV1 cells were treated with 20 nM of siRNA against either Axl (siAxl) or a
negative control (siControl). After 3 days, the cells were harvested and lysed
with 0.6% SDS lysis buffer, and Axl level was analyzed by PAGE and western
blotting.
(B) CV1 cells were treated with siRNA as above and infected with SV40 at a
range of moi of 0.1–3. The percentage of infected cells was determined 48 hr
later by fluorescence-activated cell sorting (FACS) staining for T antigen.
Results for all moi were similar and averaged together. The columns present
mean ± SE; n = 6; p = 0.007.
(C) CV1 cells were incubated with either anti-Axl or a control antibody for 1 hr
prior to SV40 infection. Cells were infected with SV40 at moi of 0.1–1, and the
percentage of infected cells was determined as above. Results aremean ± SE;
n = 5; p = 0.009 (comparing anti-Axl with the isotype control treatment).
(D) CV1 cells were treated with siRNA as above and infected with Alexa Fluor
488-labeled SV40 at moi of 0.1–3. At 6 hr postinfection, the cells were washed
and trypsinized to remove any surface-bound virus. Mean fluorescence
intensity wasmeasured by FACS. Results are mean ± SE; n = 10; p = 43 105.
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results (Figure 4B).
Axl Participates in the SV40 Infection Cycle
The results so far suggest that Axl participates in SV40 cell
recognition, but does it function in the infection process? A com-
mon way to evaluate SV40 infection is by measuring the percent
of infected cells that express T antigen 48 hr postinfection. SV40
infection was decreased by 40% (38% ± 10%; n = 6; p value =
0.007; Figure 5B) when Axl levels were reduced by 80%–90%
using small interfering RNA (siRNA) (Figure 5A), indicating that
Axl indeed participates in the infection. Comparable reduction
was observed for infections at a range of multiplicities (moi)
from 0.1 to 3. Similar results were also obtained when Axl was
blocked by antibodies prior to SV40 infection (Figure 5C). The
finding that SV40 infection was not completely inhibited in these
experiments suggests redundancy of cellular receptors used by
SV40. This is not surprising considering the large number
of candidate SV40 receptors that were revealed by the ligand
mimicry screen (Figure 2).70 Cell Host & Microbe 14, 63–73, July 17, 2013 ª2013 Elsevier Inc.Axl, being a protein receptor that induces cellular signaling,
might participate in infection processes subsequent to cell entry.
T antigen-positive cells were scored at 48 hr postinfection to
allow the virally encoded gene to express. We next tested the
effect of Axl knockdown on SV40 cell entry. CV1 cells, treated
with siRNA as above, were infected with fluorescently labeled
virus. Following the adsorption period, the cells were washed,
and nonadsorbed virus was removed. The cells were harvested
for analysis at 6 hr, before entry of the viral DNA to the nucleus
(Butin-Israeli et al., 2011). At that time, the remaining noninternal-
ized virus was removed by the trypsinization step. The mean
fluorescence intensity of the cells was determined by flow
cytometry. According to this assay, SV40 entry was reduced
by only25% (26% ± 4%; n = 10; p value = 43 105; Figure 5D)
compared to the 40% reduction in the percentage of T antigen-
expressing cells. These data suggest that Axl participates in cell
entry as well as subsequent steps of the infection cycle that lead
to T-antigen expression.
Taken together, our data indicate that Axl has multiple roles in
the SV40 infection process, both during viral entry and by facili-
tating progression of the infection cycle, nuclear entry, and viral
gene expression. We have previously demonstrated that PLCg
and AKT-1 pathways are activated by SV40 soon after adsorp-
tion and that both are required for the infection to proceed
(Butin-Israeli et al., 2010). Notably, both PLCg and AKT-1 are
known to be activated by Axl (Linger et al., 2008), which may
account for the role of Axl in the progression of SV40 infection.
DISCUSSION
The infection process of viruses and some bacteria depends on
recognition of host cell receptors. It is therefore not surprising
that pathogens have evolved diverse strategies to ensure that
these interactions take place. We have shown here that one
such strategy is structural mimicry of host ligands. We found
that surface proteins of six pathogens, which are evolutionary
unrelated, are structurally similar to host ligands, providing
strong support for the ligand mimicry concept. Perhaps the
most striking example is herpes simplex virus 1, for which we
have identified all three known host receptors just by screening
for structural homologs of its surface protein glycoprotein D.
We hypothesized that the ligand mimicry concept would facil-
itate screening for unknown virus-receptor interactions. As a
proof of concept, we applied it to screen for unknown SV40
receptors. Most of the potential receptors identified by the
bioinformatics screen were found to bind SV40 by the high-
throughput assay on the microfluidics platform. Furthermore,
two of the receptor families thus predicted to be used by
SV40, integrins and TAM receptors, have already been experi-
mentally validated. Validation of integrins has been recently
demonstrated by Stergiou et al., (2013), and validation of TAM
receptors is demonstrated in the present study. These findings
demonstrate that ligand mimicry provides a powerful strategy
for identification of receptors.
Here we demonstrated that SV40 capsids, as well as free VP1
pentamers, bound Axl and Tyro3 at high affinities. The lower
affinity found for free pentamers, compared to complete cap-
sids, provided support for our structural in silico model, which
proposed that these receptors bind at the regions formed by
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ultracentrifugation suggested that 20 receptor molecules
may bind a single capsid, consistent with the model proposed
by Ewers et al., (2010) for virus entry via GM1 gangliosides at
membrane rafts. The model proposes that the virus particle
attaches to multiple GM1 molecules simultaneously, leading to
its engulfment by the membrane and creating a local negative
curvature. Thus, onemay envisage that SV40may concomitantly
bind to multiple Axl molecules that are present at close proximity
on the cell membrane.
SV40 colocalizes with Axl at the cellular membrane immedi-
ately after adsorption, as shown by immunostaining as well as
by PLA. Binding is transient, indicating that the function of Axl
is different from that of GM1, which has been reported by others
to internalize with the virus (Qian et al., 2009). We propose that
the role of binding to Axl is to initiate signaling events that
promote SV40 entry and infection. This is consistent with the
overlap in signaling that is activated both by TAM receptors
(reviewed in Linger et al., 2008) and by SV40 (Butin-Israeli
et al., 2010; Pelkmans et al., 2005), including PLCg, AKT-1,
Src, and actin reorganization. Additionally, Axl and the other
TAM receptors may play a role in the low immunogenicity of
SV40 in model animals (Arad et al., 2005; Kondo et al., 1998)
since they act as pleiotropic inhibitors of the innate immune
response (Rothlin et al., 2007).
Axl participates in SV40 infection, as shown by its blocking
with antibodies and downregulation with siRNA. However, both
treatments led to only partial decrease in entry and infectivity.
This is most likely due to redundancy of candidate receptors
for SV40 identified in our bioinformatics screen (and confirmed
to bind to SV40 in vitro) as well as the abundant GM1. In addition,
SV40 was previously shown to utilize major histocompatibility
complex (MHC) class I molecules at the cell surface for entry (At-
wood and Norkin, 1989; Breau et al., 1992).
The ligand mimicked by SV40, Gas6, is a ubiquitous mamma-
lian serum protein. Remarkably, some enveloped viruses,
including lentiviruses, ebola, lassa, and vaccinia, use Gas6 and
TAM receptors to enter cells via apoptotic mimicry. They do so
by incorporating phosphatidylserine (PS) into their membrane
during the budding step. PS is normally found in the inner leaflet
of the plasma membrane and becomes exposed on the surface
during apoptosis, thereby tagging the apoptotic cell for phago-
cytosis by macrophages and dendritic cells. The process is
dependent on Gas6, which binds to PS and mediates phagocy-
tosis of the PS-tagged cell via activation of Mer, one of the TAM
receptors (Lemke and Burstyn-Cohen, 2010). Viruses that
contain PS in their envelopes use this mechanism for receptor
recognition and cell entry (Hunt et al., 2011; Mercer, 2011;
Morizono et al., 2011; Shimojima et al., 2012). Interestingly, these
viruses seem to prefer using Axl, which is expressedmore widely
than Mer and Tyro3. Thus, TAM receptors are emerging as
favorite viral receptors for both enveloped and nonenveloped
viruses.
Screening for unknown pathogen receptors by the ligandmim-
icry strategy, as described here, is a powerful tool, yet limited by
the a priori requirement for the structure of the MSP. Successful
screening also relies on availability of the structure of the
mimicked ligand as well as on information on receptor(s) used
by that ligand. These limitations are becoming less and lessCrestrictive, as data on both protein structures and protein-protein
interactions are being generated at an ever-increasing rate. Pro-
tein-protein templates are already available for almost all inter-
actions of structurally characterized proteins (Vakser, 2013).
Thus, based on structural information, a recent large-scale study
was able to accurately reconstruct the known protein interaction
networks as well as detect interactions that were subsequently
successfully validated by experiments (Zhang et al., 2012). In
this study, we have applied a similar approach to specifically
detect host-pathogen interactions.
Our bioinformatics study strongly supports the notion that
many pathogens utilize multiple receptors. Remarkably, for
each of the 24 MSPs screened here we found a number of
host ligands homologs, predicting that they may potentially
use other receptors in addition to their known ones. This finding
raises the possibility that somemicrobes are quite flexible in their
requirements for cell recognition, with significant implications to
their cellular tropism.
In the examples studied here, structural homology between
MSPs and the ligands that they mimic is restricted to the partic-
ular domain that interacts with the host receptor. In addition,
sequence identity between the MSPs and the mimicked ligands
is low in spite of the significant structural homology. This sce-
nario is typical for convergent evolution, while divergent evolu-
tion cannot be ruled out. Convergent evolution of ligand mimicry
is further supported by the annotation of most MSPs to protein
folds that are different from those of their mimicked ligands
(Table S2). Intriguingly recent structural studies revealed that
the folded topology of capsid proteins is unique (Cheng and
Brooks, 2013). This unique fold was attributed to specific con-
straints during evolution, underlined by the requirement of viral
capsid proteins to assemble into cage-like architecture. Taken
together, these findings support the notion that ligand mimicry
arose, in many cases, by convergent evolution. It is conceivable
that small viruses use convergent evolution to expand their
repertoire of receptors, as they are under stringent evolutionary
pressure to maintain their genome size.
The complex interactions of pathogens with their hosts are
shaped by the ongoing evolutionary arms race. This has resulted
in formidable antiviral and antibacterial responses in the host and
equally elaborate immune evasion strategies of pathogens.
Remarkably, as an offshoot of our screen, we have found that
all seven bacterial and viral MSPs that use ligand mimicry for
cell recognition also mimic immunity-related proteins, presum-
ably to evade host immunity. These include complement and
coagulation factors, integrins, and histocompatibility leukocyte
antigen (HLA) components.
In conclusion, we propose that ligand mimicry is a widespread
mechanism used by bacteria and viruses to interact with host
receptors. These interactions likely play a role in cell entry of
pathogens aswell as in their immune evasion. Importantly, ligand
mimicry can be used to identify unknown pathogen-receptor
interactions that provide attractive targets for drug design.EXPERIMENTAL PROCEDURES
Screening for Structural Homology between Pathogen Surface
Proteins and Native Ligands
A flow chart of the screening process is presented in Figure S1.ell Host & Microbe 14, 63–73, July 17, 2013 ª2013 Elsevier Inc. 71
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CV1 cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM)
containing 10% FBS. Recombinant Axl and Tyro3 were purchased from
R&D Systems.
Production, Purification, and Labeling of SV40, VLPs, and VP1
Pentamers
SV40 and VLPs were produced and purified as previously described (Ben-
nun-Shaul et al., 2009; Mukherjee et al., 2007; Rosenberg et al., 1981). VP1
pentamers were prepared by disassembly of purified VLPs (Kler et al., 2012).
SV40 or VLPs were labeled using commercial kits according to the manufac-
turers’ instructions (Abcam and Molecular Probes).
SV40 Infection
CV1 cells were infected using standard procedures (Butin-Israeli et al., 2010).
Adsorption was at 4C for 30 min.
Plasmon Surface Resonance Experiments
In vitro binding of Axl or Tyro3 to VLPs or VP1 pentamers was determined by
Biacore 3000 (GE Healthcare).
In Vitro Binding Assay Using a Microfluidics Platform
To validate predictions of the structural study, we used an integratedmicroflui-
dic approach (Ben-Ari et al., 2013; Gerber et al., 2009). Receptors of interest
were expressed from synthetic genes in a microfluidic protein array and tested
for SV40 binding.
Immunofluorescence Colocalization and Proximity Ligation Assay
For immunofluorescence, cells infected with fluorescently labeled SV40 or
VLPs were fixed and stained with appropriate antibodies. PLA samples were
processed using Duolink In Situ Orange Starter kit (Olink Bioscience) accord-
ing to the manufacturer’s protocol. Samples were visualized by an LSM 710
confocal microscope (Zeiss).
SV40 Entry Analysis
Cells were infected with Alexa Fluor 488-labeled SV40. Mean fluorescence of
internalized viruses was determined at 6 hr postinfection by FACSCalibur.
SV40 Infectivity Analysis
Infected cells were stained for T antigen and analyzed by flow cytometry as
previously reported (Drayman et al., 2010).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, two tables, and onemovie and can be found with this article online
at http://dx.doi.org/10.1016/j.chom.2013.05.005.
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